PATENT CLAIM ANALYSIS

Application Number: 15949993
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "085200"]

Abstract:
The present disclosure relates to a composition for treating or preventing an inflammatory disease, and more particularly, to a composition for treating or preventing a herpes simplex virus infection containing interleukin-15 and interleukin-15 receptor alpha-Fc.

Claim (Index 5):
The method of  claim 1 , wherein the infectious disease caused by herpes simplex virus is selected from the group consisting of herpes labialis, angular herpes, genital herpes simplex, ocular herpes, brain herpes infectious encephalitis, Mollaret's meningitis, and neonatal herpes.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13769179', '15083998', '13391615', '13854903', '15213991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671504936319742
- 35 USC 102 Novelty (BERT): 0.5027980114620594
- Combined Prediction Score: 0.7407152454149827
- Mean Citation Score: 250.808238
- Max Citation Score: 255.71124
- Similarity Product: 177.17704512225868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test